Lijuan Chen

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Multiple Myeloma

Intellectual Disability

Peripheral Blood

Ejection Fraction

Top Venues

Discover. Oncology

Clinical epigenetics

Journal of immunology research

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Jue Zhang, Ting Zhang, Ye Yao, Xuxing Shen, Yuanyuan Jin, Run Zhang, Lijuan Chen
Low serum total cholesterol levels predict inferior prognosis of patients with POEMS syndrome. Discover. Oncology 15 (1) (2024)
Jue Zhang, Ting Zhang, Ye Yao, Xuxing Shen, Yuanyuan Jin, Run Zhang, Lijuan Chen
Low serum total cholesterol levels predict inferior prognosis of patients with POEMS syndrome. Discover. Oncology 15 (1) (2024)
Jue Zhang, Ting Zhang, Ye Yao, Xuxing Shen, Yuanyuan Jin, Run Zhang, Lijuan Chen
Low serum total cholesterol levels predict inferior prognosis of patients with POEMS syndrome. Discover. Oncology 15 (1) (2024)
Lina Zhang, Run Zhang, Jing Wang, Ying Chen, Chun Qiao, Qinglin Shi, Yuanyuan Jin, Xuxing Shen, Jianyong Li, Lijuan Chen
Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma. Clinical epigenetics 14 (1) (2022)
Yanping Liu, Ziwen Duan, Fang Li, Xiao Zhang, Ruize Chen, Hua Lu, Sixuan Qian, Hanxin Wu, Lijuan Chen, Yu Zhu, Han Zhu, Kourong Miao
Acute kidney injury in peripheral blood haploidentical hematopoietic stem cell transplantation: should attract enough attention. Bone marrow transplantation 57 (9) (2022)
Yuan Xia, Jue Zhang, Jing Li, Lina Zhang, Jianyong Li, Lei Fan, Lijuan Chen
Cytopenias following anti-CD19 chimeric antigen receptor (CAR) T cell therapy: a systematic analysis for contributing factors. Annals of medicine 54 (1) (2022)
Lina Zhang, Shuai Wang, Ji Xu, Run Zhang, Han Zhu, Yujie Wu, Liying Zhu, Jianyong Li, Lijuan Chen
Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy. Experimental hematology & oncology 10 (1) (2021)
Xuxing Shen, Chao Wu, Meng Lei, Qing Yan, Haoyang Zhang, Lina Zhang, Xueyuan Wang, Ye Yang, Jianyong Li, Yongqiang Zhu, Lijuan Chen
Anti-tumor activity of a novel proteasome inhibitor D395 against multiple myeloma and its lower cardiotoxicity compared with carfilzomib. Cell death & disease 12 (5) (2021)
Chao Wu, Lina Zhang, Qierra R Brockman, Fenghuang Zhan, Lijuan Chen
Chimeric antigen receptor T cell therapies for multiple myeloma. Journal of hematology & oncology 12 (1) (2019)
Xianghua Huang, Chengcheng Fu, Lijuan Chen, Wencui Chen, Guisheng Ren, Jinzhou Guo, Liang Zhao, Caihong Zeng, Haitao Zhang, Dehua Gong, Qiang Ren, Zhihong Liu
Combination of bortezomib in the induction, conditioning and consolidation with autologous hematopoietic stem cell transplantation in patients with immunoglobulin light chain amyloidosis. American journal of hematology 94 (4) (2019)
Hua Bai, Huayuan Zhu, Qing Yan, Xuxing Shen, Xiupan Lu, Juejin Wang, Jianyong Li, Lijuan Chen
TRPV2-induced Ca2+-calcineurin-NFAT signaling regulates differentiation of osteoclast in multiple myeloma. Cell communication and signaling : CCS 16 (1) (2018)
Qinglin Shi, Lijuan Chen
Cereblon: A Protein Crucial to the Multiple Functions of Immunomodulatory Drugs as well as Cell Metabolism and Disease Generation. Journal of immunology research 2017 (2017)